Qiu Miaozhen, Hu Jianming, Yang Dajun, Cosgrove David Peter, Xu Ruihua
Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Oncotarget. 2015 Nov 17;6(36):38658-66. doi: 10.18632/oncotarget.6130.
More and more evidences suggest that primary colon and rectum tumors should not be considered as a single disease entity. In this manuscript, we evaluate the metastatic patterns of colon and rectum cancers and analyze the potential distribution of metastatic disease in these two malignancies. Data queried for this analysis include colorectal adenocarcinoma (2010-2011) from the Surveillance, Epidemiology, and End Results Program (SEER) database. Metastatic distribution information was provided for liver, lung, bone and brain. All of statistical analyses were performed using the Intercooled Stata 13.0 (Stata Corporation, College Station, TX). All statistical tests were two-sided. Totally, there were 46,027 eligible patients for analysis. We found that colon cancer had a higher incident rate of liver metastasis than rectum cancer (13.8% vs 12.3%), while rectum cancer had a higher incident rate of lung (5.6% vs 3.7%) and bone (1.2% vs 0.8%) metastasis than colon cancer, P<0.001. Colorectal cancer patients with lung metastasis had a higher risk of bone (10.0% vs 4.5%) or brain metastasis (3.1% vs 0.1%) than patients without lung metastases. The 1-year cause-specific survival was not significant different for bone or brain metastasis patients with and without lung metastasis (32.9% vs 38.7%, P=0.3834 for bone, 25.8% vs 36.9%, P=0.6819 for brain). Knowledge of these differences in metastatic patterns may help to better guide pre-treatment evaluation of colorectal cancer patients, especially in making determinations regarding curative-intent interventions.
越来越多的证据表明,原发性结肠癌和直肠癌不应被视为单一的疾病实体。在本手稿中,我们评估了结肠癌和直肠癌的转移模式,并分析了这两种恶性肿瘤中转移疾病的潜在分布。本次分析所查询的数据包括来自监测、流行病学和最终结果计划(SEER)数据库的结直肠腺癌(2010 - 2011年)。提供了肝脏、肺、骨和脑的转移分布信息。所有统计分析均使用Intercooled Stata 13.0(Stata公司,德克萨斯州大学站)进行。所有统计检验均为双侧检验。总共有46,027名符合条件的患者可供分析。我们发现,结肠癌肝转移的发生率高于直肠癌(13.8%对12.3%),而直肠癌肺转移(5.6%对3.7%)和骨转移(1.2%对0.8%)的发生率高于结肠癌,P<0.001。有肺转移的结直肠癌患者发生骨转移(10.0%对4.5%)或脑转移(3.1%对0.1%)的风险高于无肺转移的患者。有和无肺转移的骨或脑转移患者的1年病因特异性生存率无显著差异(骨转移:32.9%对38.7%,P = 0.3834;脑转移:25.8%对36.9%,P = 0.6819)。了解这些转移模式的差异可能有助于更好地指导结直肠癌患者的治疗前评估,特别是在做出关于根治性干预的决定时。